Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NANP | Q8TBE9 | 2/20 | 0.37 |
| ▸ | CD22 | P20273 | 7/20 | 0.35 |
| ▸ | MAG | P20916 | 3/20 | 0.34 |
| ▸ | SELL | P14151 | 1/20 | 0.33 |
| ▸ | SELP | P16109 | 1/20 | 0.33 |
| ▸ | NEU2 | Q9Y3R4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28236568 | 1.00 | L3MBTL1 (0.43) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL358280 | 1.00 | L3MBTL1 (0.43) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL27469082 | 1.00 | L3MBTL1 (0.43) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL28783926 | 0.92 | L3MBTL1 (0.42) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL3415586 | 0.91 | L3MBTL1 (0.41) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL5552010 | 0.91 | L3MBTL1 (0.44) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL3411770 | 0.91 | L3MBTL1 (0.41) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL28470509 | 0.89 | L3MBTL1 (0.44) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL8975247 | 0.89 | L3MBTL1 (0.42) | L3MBTL1NANPCD22MAGSELL | |
| SCHEMBL28463220 | 0.89 | L3MBTL1 (0.45) | L3MBTL1NANPCD22MAGSELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106459969-A | Compositions and methods for modulating growth hormone receptor expression | IONIS制药公司 | 2017-02-22 | — | — | CN | claimed |
| CN-109331185-B | Drug containing Liver targeting ligands specific and pth receptor agonist | 厦门甘宝利生物医药有限公司 | 2019-11-29 | — | — | CN | disclosed |
| CN-110079524-A | For adjusting the composition and method of HBV and TTR expression | IONIS制药公司 | 2019-08-02 | — | — | CN | disclosed |
| CN-110066795-A | For adjusting the composition and method of HBV and TTR expression | IONIS制药公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-110042098-A | For adjusting the composition and method of HBV and TTR expression | IONIS制药公司 | 2019-07-23 | — | — | CN | disclosed |
| CN-109331185-A | Drug containing Liver targeting ligands specific and pth receptor agonist | 厦门甘宝利生物医药有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-108064162-A | Conjugated antisense compounds and uses thereof | IONIS制药公司 | 2018-05-22 | — | — | CN | disclosed |